Table of Contents
1. Overview and Scope
1.1. Research goal & scope
1.2. Research assumptions
1.3. Research Methodology
1.3.1. Primary data sources
1.3.2. Secondary data sources
1.4. Key take-away
1.5. Stakeholders
2. Executive Summary
2.1. Market Definition
2.2. Market Segmentation
3. Omega 3 Market Insights
3.1. Omega 3 – Industry snapshot
3.2. Omega 3 - Ecosystem analysis
3.3. Omega 3 Market Dynamics
3.3.1. Omega 3 – Market Forces
3.3.1.1. Omega 3 Market Driver Analysis
3.3.1.2. Omega 3 Market Restraint/Challenges analysis
3.3.1.3. Omega 3 Market Opportunity Analysis
3.3.2. Industry analysis - Porter's five force
3.3.2.1. Bargaining power of supplier
3.3.2.2. Bargaining power of buyer
3.3.2.3. Threat of substitute
3.3.2.4. Threat of new entrant
3.3.2.5. Degree of competition
3.3.3. Omega 3 Market PEST Analysis, 2016
3.3.4. Omega 3 Market Value Chain Analysis
3.3.5. Omega 3 Industry Trends
3.3.6. Competitive Ranking Analysis
4. Omega 3 Market Size and Forecast, 2017-2026 by Type
4.1. Key Findings
4.2. Docosahexaenoic Acid (DHA)
4.3. Eicosapentaenoic Acid (EPA)
4.4. Alpha-Linolenic Acid (ALA)
5. Omega 3 Market Size and Forecast, 2017-2026 by Source
5.1. Key Findings
5.2. Plant Sources
5.3. Marine Sources
5.4. Others
6. Omega 3 Market Size and Forecast, 2017-2026 by Application
6.1. Key Findings
6.2. Functional Food and Supplements
6.3. Pharmaceutical
6.4. Infant Formula
6.5. Animal Feed
6.6. Others
7. Omega 3 Market Size and Forecast, 2017-2026 by Region
7.1. Key Findings
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.3. Europe
7.3.1. Germany
7.3.2. UK
7.3.3. France
7.3.4. Italy
7.3.5. Rest of Europe
7.4. Asia-Pacific
7.4.1. China
7.4.2. India
7.4.3. Japan
7.4.4. Rest of Asia-Pacific
7.5. Latin America
7.5.1. Brazil
7.6. Middle East & Africa
8. Company Profiles
8.1. Omega Protein Corporation
8.1.1. Overview
8.1.2. Financials
8.1.3. Product Benchmarking
8.1.4. Recent Developments
8.2. Croda International PLC
8.2.1. Overview
8.2.2. Financials
8.2.3. Product Benchmarking
8.2.4. Recent Developments
8.3. Arista Industries Inc.
8.3.1. Overview
8.3.2. Financials
8.3.3. Product Benchmarking
8.3.4. Recent Developments
8.4. Cargill, Inc.
8.4.1. Overview
8.4.2. Financials
8.4.3. Product Benchmarking
8.4.4. Recent Developments
8.5. Royal DSM
8.5.1. Overview
8.5.2. Financials
8.5.3. Product Benchmarking
8.5.4. Recent Developments
8.6. Pharma Marine AS
8.6.1. Overview
8.6.2. Financials
8.6.3. Product Benchmarking
8.6.4. Recent Developments
8.7. GC Reiber Oils
8.7.1. Overview
8.7.2. Financials
8.7.3. Product Benchmarking
8.7.4. Recent Developments
8.8. Nordic Naturals Inc.
8.8.1. Overview
8.8.2. Financials
8.8.3. Product Benchmarking
8.8.4. Recent Developments
8.9. Reckitt Benckiser Group plc
8.9.1. Overview
8.9.2. Financials
8.9.3. Product Benchmarking
8.9.4. Recent Developments
8.10. Pharma Nord B.V.
8.10.1. Overview
8.10.2. Financials
8.10.3. Product Benchmarking
8.10.4. Recent Developments
8.11. Pharmavite LL
8.11.1. Overview
8.11.2. Financials
8.11.3. Product Benchmarking
8.11.4. Recent Developments
8.12. Natrol LLC
8.12.1. Overview
8.12.2. Financials
8.12.3. Product Benchmarking
8.12.4. Recent Developments